Skelaxin: Targeted Muscle Relaxation for Acute Musculoskeletal Pain
| Product dosage: 400mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.12 | $63.64 (0%) | 🛒 Add to cart |
| 60 | $1.68 | $127.28 $100.62 (21%) | 🛒 Add to cart |
| 90 | $1.52 | $190.92 $136.74 (28%) | 🛒 Add to cart |
| 120 | $1.45 | $254.56 $173.72 (32%) | 🛒 Add to cart |
| 180 | $1.37 | $381.84 $246.82 (35%) | 🛒 Add to cart |
| 270 | $1.33
Best per pill | $572.76 $358.62 (37%) | 🛒 Add to cart |
Synonyms | |||
Skelaxin (metaxalone) is a centrally-acting skeletal muscle relaxant indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions. It works by depressing polysynaptic reflexes in the spinal cord and subcortical areas of the brain, leading to a reduction in skeletal muscle hyperactivity without directly affecting muscle fibers. As a non-benzodiazepine agent, it offers a favorable side effect profile for appropriate patients, providing effective muscle spasm relief while minimizing sedation compared to some alternatives. Its mechanism, while not fully elucidated, provides a valuable therapeutic option in comprehensive pain management protocols.
Features
- Active ingredient: 800mg metaxalone per tablet
- Centrally-acting skeletal muscle relaxant mechanism
- Non-narcotic, non-addictive formulation (with appropriate use)
- Simple twice-daily dosing regimen
- Minimal direct effect on muscle contractility
- Rapid onset of action within one hour
- Compatibility with most common analgesic regimens
Benefits
- Provides effective relief from acute musculoskeletal pain and spasms
- Reduces muscle stiffness and improves range of motion
- Minimizes interference with daily activities due to reduced sedation
- Supports faster recovery from musculoskeletal injuries
- Complements physical therapy and rehabilitation efforts
- Offers predictable pharmacokinetics with consistent dosing
Common use
Skelaxin is primarily prescribed for the management of acute musculoskeletal conditions characterized by muscle spasm and pain. These typically include back strains, whiplash injuries, muscle tears, and post-surgical musculoskeletal pain. It is most effective when used as part of a comprehensive treatment plan that may include rest, physical therapy, and other analgesics. The medication is generally prescribed for short-term use (typically 2-3 weeks) during the acute phase of musculoskeletal injury, as its efficacy in chronic conditions has not been established.
Dosage and direction
The recommended adult dosage of Skelaxin is 800 mg administered three to four times daily. Tablets should be taken whole with a full glass of water and may be administered with or without food, though taking with food may reduce gastrointestinal discomfort. The duration of therapy should not exceed two to three weeks unless specifically directed by a healthcare provider, as adequate evidence of effectiveness for more prolonged use is lacking. Dosage adjustment may be necessary in elderly patients or those with hepatic impairment.
Precautions
Patients should be cautioned about operating machinery or driving until they have determined how Skelaxin affects them, as drowsiness may occur. Alcohol consumption should be avoided during therapy due to additive CNS depression effects. Use with caution in patients with hepatic or renal impairment, as metaxalone is metabolized in the liver and excreted renally. Elderly patients may be more sensitive to the effects of Skelaxin and typically require lower doses. Periodic assessment of liver function may be warranted during extended therapy.
Contraindications
Skelaxin is contraindicated in patients with known hypersensitivity to metaxalone or any component of the formulation. It should not be used in patients with significantly impaired hepatic function or history of drug-induced hemolytic anemia. Contraindicated in patients with severe renal impairment (creatinine clearance <30 mL/min). Should not be administered to patients with a history of seizures or epilepsy, as metaxalone may lower the seizure threshold. Not recommended during pregnancy unless potential benefits outweigh risks.
Possible side effect
Common side effects include drowsiness (which may diminish with continued therapy), dizziness, headache, and nausea. Gastrointestinal disturbances such as vomiting, upset stomach, and constipation may occur. Nervous system effects including irritability, nervousness, and insomnia have been reported. Less frequently, patients may experience rash, pruritus, or hypersensitivity reactions. Serious but rare side effects include hemolytic anemia, jaundice, and severe dermatological reactions. Most side effects are dose-related and often transient.
Drug interaction
Skelaxin may potentiate the effects of alcohol, barbiturates, benzodiazepines, and other CNS depressants. Concurrent use with MAO inhibitors may increase the risk of adverse reactions. May enhance the effects of warfarin and other oral anticoagulants, requiring closer monitoring of coagulation parameters. Use with anticholinergic agents may increase the risk of urinary retention and constipation. Metaxalone may affect the metabolism of certain hepatically-metabolized drugs through unknown mechanisms.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next scheduled dose. In that case, the missed dose should be skipped and the regular dosing schedule resumed. Patients should not double the dose to make up for a missed one, as this may increase the risk of adverse effects. If multiple doses are missed, patients should contact their healthcare provider for guidance on resuming therapy.
Overdose
Symptoms of overdose may include severe drowsiness, dizziness, nausea, vomiting, and CNS depression. In severe cases, respiratory depression, coma, or seizures may occur. Treatment is primarily supportive and symptomatic, with attention to maintaining adequate respiratory function. Gastric lavage may be considered if presentation is early after ingestion. There is no specific antidote for metaxalone overdose. Hemodialysis is not likely to be effective due to high protein binding. Medical attention should be sought immediately for suspected overdose.
Storage
Store at controlled room temperature between 20°C to 25°C (68°F to 77°F). Protect from light and moisture. Keep in the original container with the lid tightly closed. Do not store in bathroom areas where moisture levels may be higher. Keep out of reach of children and pets. Properly discard any expired or unused medication according to local regulations, typically through drug take-back programs.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Skelaxin is a prescription medication that should be used only under the supervision of a qualified healthcare provider. Individual response to medication may vary, and not all side effects are listed here. Patients should consult their healthcare provider for personalized medical advice and report any adverse reactions promptly. The full prescribing information should be reviewed before initiating therapy.
Reviews
Clinical studies demonstrate Skelaxin’s efficacy in reducing muscle spasm and pain scores compared to placebo. In randomized controlled trials, patients receiving metaxalone showed significant improvement in muscle spasm, pain intensity, and range of motion measurements. Many clinicians report satisfactory results in appropriate patient populations, particularly noting the favorable side effect profile compared to other muscle relaxants. Patient satisfaction surveys indicate improved functional outcomes when used as directed for acute musculoskeletal conditions. Long-term safety data beyond three weeks of continuous use remains limited.